SAT0359 THE COURSE OF MOUTH OPENING AND ITS RELATIONSHIP WITH DISEASE CHARACTERISTICS, GLOBAL FUNCTIONING, HEALTH-RELATED QUALITY OF LIFE AND MOUTH HANDICAP IN PATIENTS WITH SYSTEMIC SCLEROSIS
Results: 382 patients were included with mean age 54±14 years, 83% female and 25% diffuse cutaneous SSc. Mean MMO during 6 years of follow-up ranged from 39.4 to 42.5 mm. The annual mean percentage of patients with microstomia was 9%, range 6 to 12% (Figure 1a) . A decrease in MMO between two consecutive annual measurements was observed in 5 to 17% of patients, mean 12% ( Figure  1b ). More extended cutaneous involvement, peripheral vasculopathy, pulmonary and gastrointestinal involvement at baseline were predictive for decreasing MMO over time ( Mi-2, Jo-1, SRP, PL-7, PL-12, EJ, OJ) and Myositisassociated autoantibodies (MAA; Ku, PM-Scl) at the same time, which is used commercially in Western countries. However, the difference between utility of MESA and that of EURO haven't be disclosed. Objectives: To clarify difference between utility of EURO and MESA, and extract the problem of respective examination. Methods: We enrolled 58 patients diagnosed DM/PM in our facility. Polymyositis (PM) and dermatomyositis (DM) were diagnosed according to Bohan and Peter's criteria.
1) The MAA and MSA were analyzed using MESA and EURO. In case of MESA (+), MSA (anti-Jo1, anti-PL7, anti-PL12, anti-KS) were identified by specific ELISA. When those results were different, we analyzed by immunoprecipitation. And we analyzed the association between each autoantibody and clinical features. Results: MSA and MAA were detected in 43/58 (74%) (anti-PL7: 12, anti-Jo1: 7, anti-EJ: 3, anti-PL12: 1, anti-OJ: 0, anti-Ro52: 27, anti-PM-Scl75: 7, anti-Ku: 6, anti-PM-Scl100: 1) by EURO. On the other hand, MSA and MAA were detected in 30/58 (52%) (anti-PL7: 9, anti-Jo1: 7, anti-EJ: 4, TIF1γ: 4, MDA5: 3, U1RNP: 3) by MESA. Five patients were MESA (-) and EURO (-). In the case of ARS positive patient, Two of EURO (-) patients was positive in MESA, respectively Jo1 and EJ. Three of MESA (-) patients was positive in EURO. Although MESA(-) and EURO(+) patients had plural MSA and MAA (PL7+Jo1, PL7+PL12, PL7+Ku), MSA and MAA weren't detected by immunoprecipitation in MESA(-) and EURO(+) patients. Two of patients that detected plural MSA or MAA had rapid progressive ILD.
(Association between clinical manifestations and MSA, MAA) All patients with anti-ARS (anti-Jo-1, anti-PL-7, anti-PL-12 and anti-EJ) had ILD. In addition, anti-ARS were associated with arthritis and mechanic's hands. Anti-Mi-2 positive patients didn't have ILD. Patients detected anti-PM-Scl75, anti-PM-Scl100, anti-Ku were almost overlap syndrome. All of Anti-SRP positive patients was PM. Conclusions: EURO is a convenient and reliable method useful for detection of MSA and MAA. It was suggested the patients whom plural antibodies were detected by EURO have unique clinical course in others. 
